Selected research
Industry Growth & Trends
Global Tumor MRD Detection Products and Services Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Tumor MRD Detection Products and Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Tumor MRD Detection Products and Services is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Tumor MRD Detection Products and Services is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Tumor MRD Detection Products and Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Tumor MRD Detection Products and Services market include Natera, Guardant Health, SeraCare Life Sciences, Inc. (LGC), Adaptive Biotechnologies, Invitae(ArcherDX), Cergentis B.V., LexentBio(Foundation Medicine), Genecast and Genetron Health, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Tumor MRD Detection Products and Services market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Tumor MRD Detection Products and Services market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Tumor MRD Detection Products and Services market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Tumor MRD Detection Products and Services.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Tumor MRD Detection Products and Services market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Tumor MRD Detection Products and Services Market by Company
Natera
Guardant Health
SeraCare Life Sciences, Inc. (LGC)
Adaptive Biotechnologies
Invitae(ArcherDX)
Cergentis B.V.
LexentBio(Foundation Medicine)
Genecast
Genetron Health
Acornmed
Shenzhen Neoimmune Co., Ltd.
Tung Tree Gene
Geneseeq
BGI Genomics
Burning Rock Biotech Limited
GenePlus
Tumor MRD Detection Products and Services Segment by Type
MRD Detection Products
In Vitro Diagnostic (IVD) Test Service
Tumor MRD Detection Products and Services Segment by Application
Lung Cancer
Digestive System Tumors (Colorectal Cancer/Pancreatic Cancer/Liver Cancer/Gastric Cancer)
Breast Cancer and Gynecological Tumors (Ovarian Cancer/Cervical Cancer)
Urinary System Tumors (Bladder Cancer)
Central Nervous System Tumors
Soft Tissue and Bone Tumors
Thyroid Cancer and Melanoma
Tumor MRD Detection Products and Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tumor MRD Detection Products and Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tumor MRD Detection Products and Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tumor MRD Detection Products and Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Tumor MRD Detection Products and Services companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- MRD Detection Products
- In Vitro Diagnostic (IVD) Test Service
Applications
- Lung Cancer
- Digestive System Tumors (Colorectal Cancer/Pancreatic Cancer/Liver Cancer/Gastric Cancer)
- Breast Cancer and Gynecological Tumors (Ovarian Cancer/Cervical Cancer)
- Urinary System Tumors (Bladder Cancer)
- Central Nervous System Tumors
- Soft Tissue and Bone Tumors
- Thyroid Cancer and Melanoma
Companies covered
- Natera
- Guardant Health
- SeraCare Life Sciences, Inc. (LGC)
- Adaptive Biotechnologies
- Invitae(ArcherDX)
- Cergentis B.V.
- LexentBio(Foundation Medicine)
- Genecast
- Genetron Health
- Acornmed
- Shenzhen Neoimmune Co., Ltd.
- Tung Tree Gene
- Geneseeq
- BGI Genomics
- Burning Rock Biotech Limited
- GenePlus
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Tumor MRD Detection Products and Services Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Tumor MRD Detection Products and Services Market Size by Region (2021-2032)
- 1.4.1 Global Tumor MRD Detection Products and Services Market Size by Region (2021-2026)
- 1.4.2 Global Tumor MRD Detection Products and Services Market Size by Region (2027-2032)
- 1.5 Key Regions Tumor MRD Detection Products and Services Market Size (2021-2032)
- 1.5.1 North America Tumor MRD Detection Products and Services Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Tumor MRD Detection Products and Services Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Tumor MRD Detection Products and Services Market Size Growth Rate (2021-2032)
- 1.5.4 South America Tumor MRD Detection Products and Services Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Tumor MRD Detection Products and Services Market Size Growth Rate (2021-2032)
2 Tumor MRD Detection Products and Services Market by Type
- 2.1 Type Introduction
- 2.1.1 MRD Detection Products
- 2.1.2 In Vitro Diagnostic (IVD) Test Service
- 2.2 Global Tumor MRD Detection Products and Services Market Size by Type
- 2.2.1 Global Tumor MRD Detection Products and Services Market Size Overview by Type (2021-2032)
- 2.2.2 Global Tumor MRD Detection Products and Services Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Tumor MRD Detection Products and Services Market Size Forecasted by Type (2027-2032)
- 2.3 Global Tumor MRD Detection Products and Services Market Size by Regions
- 2.3.1 North America Tumor MRD Detection Products and Services Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Tumor MRD Detection Products and Services Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Tumor MRD Detection Products and Services Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Tumor MRD Detection Products and Services Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Tumor MRD Detection Products and Services Market Size Breakdown by Type (2021-2026)
3 Tumor MRD Detection Products and Services Market by Application
- 3.1 Type Introduction
- 3.1.1 Lung Cancer
- 3.1.2 Digestive System Tumors (Colorectal Cancer/Pancreatic Cancer/Liver Cancer/Gastric Cancer)
- 3.1.3 Breast Cancer and Gynecological Tumors (Ovarian Cancer/Cervical Cancer)
- 3.1.4 Urinary System Tumors (Bladder Cancer)
- 3.1.5 Central Nervous System Tumors
- 3.1.6 Soft Tissue and Bone Tumors
- 3.1.7 Thyroid Cancer and Melanoma
- 3.2 Global Tumor MRD Detection Products and Services Market Size by Application
- 3.2.1 Global Tumor MRD Detection Products and Services Market Size Overview by Application (2021-2032)
- 3.2.2 Global Tumor MRD Detection Products and Services Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Tumor MRD Detection Products and Services Market Size Forecasted by Application (2027-2032)
- 3.3 Global Tumor MRD Detection Products and Services Market Size by Regions
- 3.3.1 North America Tumor MRD Detection Products and Services Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Tumor MRD Detection Products and Services Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Tumor MRD Detection Products and Services Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Tumor MRD Detection Products and Services Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Tumor MRD Detection Products and Services Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Tumor MRD Detection Products and Services Industry Trends
- 4.2 Tumor MRD Detection Products and Services Industry Drivers
- 4.3 Tumor MRD Detection Products and Services Industry Opportunities and Challenges
- 4.4 Tumor MRD Detection Products and Services Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Tumor MRD Detection Products and Services Revenue (2021-2026)
- 5.2 Global Tumor MRD Detection Products and Services Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Tumor MRD Detection Products and Services Key Company Headquarters & Area Served
- 5.4 Global Tumor MRD Detection Products and Services Company, Product Type & Application
- 5.5 Global Tumor MRD Detection Products and Services Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Tumor MRD Detection Products and Services Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Tumor MRD Detection Products and Services Players Market Share by Revenue in 2025
- 5.6.3 2025 Tumor MRD Detection Products and Services Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 Natera
- 6.1.1 Natera Company Information
- 6.1.2 Natera Business Overview
- 6.1.3 Natera Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 Natera Tumor MRD Detection Products and Services Product Portfolio
- 6.1.5 Natera Recent Developments
- 6.2 Guardant Health
- 6.2.1 Guardant Health Company Information
- 6.2.2 Guardant Health Business Overview
- 6.2.3 Guardant Health Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Guardant Health Tumor MRD Detection Products and Services Product Portfolio
- 6.2.5 Guardant Health Recent Developments
- 6.3 SeraCare Life Sciences, Inc. (LGC)
- 6.3.1 SeraCare Life Sciences, Inc. (LGC) Company Information
- 6.3.2 SeraCare Life Sciences, Inc. (LGC) Business Overview
- 6.3.3 SeraCare Life Sciences, Inc. (LGC) Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 SeraCare Life Sciences, Inc. (LGC) Tumor MRD Detection Products and Services Product Portfolio
- 6.3.5 SeraCare Life Sciences, Inc. (LGC) Recent Developments
- 6.4 Adaptive Biotechnologies
- 6.4.1 Adaptive Biotechnologies Company Information
- 6.4.2 Adaptive Biotechnologies Business Overview
- 6.4.3 Adaptive Biotechnologies Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Adaptive Biotechnologies Tumor MRD Detection Products and Services Product Portfolio
- 6.4.5 Adaptive Biotechnologies Recent Developments
- 6.5 Invitae(ArcherDX)
- 6.5.1 Invitae(ArcherDX) Company Information
- 6.5.2 Invitae(ArcherDX) Business Overview
- 6.5.3 Invitae(ArcherDX) Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Invitae(ArcherDX) Tumor MRD Detection Products and Services Product Portfolio
- 6.5.5 Invitae(ArcherDX) Recent Developments
- 6.6 Cergentis B.V.
- 6.6.1 Cergentis B.V. Company Information
- 6.6.2 Cergentis B.V. Business Overview
- 6.6.3 Cergentis B.V. Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Cergentis B.V. Tumor MRD Detection Products and Services Product Portfolio
- 6.6.5 Cergentis B.V. Recent Developments
- 6.7 LexentBio(Foundation Medicine)
- 6.7.1 LexentBio(Foundation Medicine) Company Information
- 6.7.2 LexentBio(Foundation Medicine) Business Overview
- 6.7.3 LexentBio(Foundation Medicine) Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 LexentBio(Foundation Medicine) Tumor MRD Detection Products and Services Product Portfolio
- 6.7.5 LexentBio(Foundation Medicine) Recent Developments
- 6.8 Genecast
- 6.8.1 Genecast Company Information
- 6.8.2 Genecast Business Overview
- 6.8.3 Genecast Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Genecast Tumor MRD Detection Products and Services Product Portfolio
- 6.8.5 Genecast Recent Developments
- 6.9 Genetron Health
- 6.9.1 Genetron Health Company Information
- 6.9.2 Genetron Health Business Overview
- 6.9.3 Genetron Health Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Genetron Health Tumor MRD Detection Products and Services Product Portfolio
- 6.9.5 Genetron Health Recent Developments
- 6.10 Acornmed
- 6.10.1 Acornmed Company Information
- 6.10.2 Acornmed Business Overview
- 6.10.3 Acornmed Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 Acornmed Tumor MRD Detection Products and Services Product Portfolio
- 6.10.5 Acornmed Recent Developments
- 6.11 Shenzhen Neoimmune Co., Ltd.
- 6.11.1 Shenzhen Neoimmune Co., Ltd. Company Information
- 6.11.2 Shenzhen Neoimmune Co., Ltd. Business Overview
- 6.11.3 Shenzhen Neoimmune Co., Ltd. Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 Shenzhen Neoimmune Co., Ltd. Tumor MRD Detection Products and Services Product Portfolio
- 6.11.5 Shenzhen Neoimmune Co., Ltd. Recent Developments
- 6.12 Tung Tree Gene
- 6.12.1 Tung Tree Gene Company Information
- 6.12.2 Tung Tree Gene Business Overview
- 6.12.3 Tung Tree Gene Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Tung Tree Gene Tumor MRD Detection Products and Services Product Portfolio
- 6.12.5 Tung Tree Gene Recent Developments
- 6.13 Geneseeq
- 6.13.1 Geneseeq Company Information
- 6.13.2 Geneseeq Business Overview
- 6.13.3 Geneseeq Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Geneseeq Tumor MRD Detection Products and Services Product Portfolio
- 6.13.5 Geneseeq Recent Developments
- 6.14 BGI Genomics
- 6.14.1 BGI Genomics Company Information
- 6.14.2 BGI Genomics Business Overview
- 6.14.3 BGI Genomics Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 BGI Genomics Tumor MRD Detection Products and Services Product Portfolio
- 6.14.5 BGI Genomics Recent Developments
- 6.15 Burning Rock Biotech Limited
- 6.15.1 Burning Rock Biotech Limited Company Information
- 6.15.2 Burning Rock Biotech Limited Business Overview
- 6.15.3 Burning Rock Biotech Limited Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Burning Rock Biotech Limited Tumor MRD Detection Products and Services Product Portfolio
- 6.15.5 Burning Rock Biotech Limited Recent Developments
- 6.16 GenePlus
- 6.16.1 GenePlus Company Information
- 6.16.2 GenePlus Business Overview
- 6.16.3 GenePlus Tumor MRD Detection Products and Services Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 GenePlus Tumor MRD Detection Products and Services Product Portfolio
- 6.16.5 GenePlus Recent Developments
7 North America
- 7.1 North America Tumor MRD Detection Products and Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Tumor MRD Detection Products and Services Market Size by Country (2021-2026)
- 7.3 North America Tumor MRD Detection Products and Services Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Tumor MRD Detection Products and Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Tumor MRD Detection Products and Services Market Size by Country (2021-2026)
- 8.3 Europe Tumor MRD Detection Products and Services Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Tumor MRD Detection Products and Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Tumor MRD Detection Products and Services Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Tumor MRD Detection Products and Services Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Tumor MRD Detection Products and Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Tumor MRD Detection Products and Services Market Size by Country (2021-2026)
- 10.3 South America Tumor MRD Detection Products and Services Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Tumor MRD Detection Products and Services Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Tumor MRD Detection Products and Services Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Tumor MRD Detection Products and Services Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst